Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study
Pinson, H., Hallaert, G., Van der Meulen, J., Dedeurwaerdere, F., Vanhauwaert, D., Van den Broecke, C., Van Dorpe, J., Van Roost, D., Kalala, J. P., Boterberg, T.Journal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-019-03334-5
Date:
November, 2019
File:
PDF, 532 KB
2019
File converter
More search results
More benefits 
